The Valley Desk

Clinical trial reportClinical cancer research : an official journal of the American Association for Cancer ResearchPublished

SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Doylestown Hospital, Temple University Hospital, Thomas Jefferson University, with Penn Medicine, Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical cancer research : an official journal of the American Association for Cancer Research
Published
Subject terms
Humans; Ovarian Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Prospective Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; CTLA-4 Antigen; Programmed Cell Death 1 Receptor; Ipilimumab
PubMed ID
39417692
PubMed Central ID
PMC11737520
Added to directory
Source checked

Report a correction or request removal